Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

DPP may help hair regrowth by improving blood vessel function under stress.

Finasteride reduces movement issues in Parkinson's disease rats.

5α-Reductase inhibitors don't cause depression.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Epristeride's metabolism in zebrafish helps improve doping detection methods.

Finasteride and dutasteride, used for prostate issues and hair loss, can cause side effects like sexual dysfunction and mental issues, which may continue even after stopping the medication, a condition called post-finasteride syndrome, for which there's currently no cure.

Dutasteride effectively treats benign prostatic hyperplasia, improving symptoms and quality of life.

Finasteride doesn't affect erections much, but may decrease libido in men.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Most legal cases about 5α-reductase inhibitors, drugs for hair loss and prostate issues, complain about side effects and delayed cancer diagnosis, with most lawsuits settled out of court.

Oral finasteride and dutasteride may negatively affect erectile function in rats.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

Combining tadalafil and finasteride improves their solubility and effectiveness.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

A new compound effectively inhibits human 5α-reductase 1.

Current treatments for recurrent ischemic priapism are not well-defined and need more research.

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

Dutasteride and finasteride don't raise erectile dysfunction risk.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

A new compound may treat benign prostatic hyperplasia better than finasteride.